Dr. Donahue has extensive experience in every phase of drug development and has served in lead statistical roles in research and development for products in allergy, analgesia, epilepsy, schizophrenia, Alzheimer’s disease, depression, addiction, surgery, orthopedics, and other areas. Dr. Donahue serves on the editorial board of the journal, Therapeutic Innovation & Regulatory Science. Dr. Donahue is currently Senior Director for Statistics at Biomimetic Therapeutics, Inc and Adjunct Associate Professor in the Department of Biostatistics at Vanderbilt University Medical Center. Dr. Donahue earned his BS in Mathematics from the University of Dayton and his PhD in Statistics from Colorado State University.

Michael Mosier, PhD is co-founder and Director of Biostatistics for EMB Statistical Solutions, a data management and statistical CRO. He has served on the editorial board of the Drug Information Journal and serves as instructor for the DIA Clinical Statistics for Nonstatisticians training course.